A Phase 2/3 trial of BX211
Latest Information Update: 22 May 2025
At a glance
- Drugs BX 211 (Primary)
- Indications Diabetic foot; Osteomyelitis
- Focus Registrational; Therapeutic Use
- Sponsors BiomX
Most Recent Events
- 22 May 2025 New trial record
- 15 May 2025 According to a BiomX media release, company is planning for a phase 2/3 trial, which is pending for feedback from the FDA.